Yuriy's goal is to accelerate medical research and improve patient care to significantly extend human lifespan and healthspan. Prior to founding Aiternis Yuriy co-founded Alvansa pharmaceutical holding with a total investment of $200M. Raised $58M in PIPE for Affitech, NASDAQ OMX Copenhagen listed cancer research company. Yuriy is the shareholder of CureLab Oncology Inc. a US based oncology gene therapy drug development company. He worked as Director of Licensing and Business Development at the HSCI - company that registered and brought to the market one of the first 5 gene therapy drugs. Graduated from the Moore School, University of South Carolina.